TY - JOUR
T1 - Assessment of hepatocellular carcinoma response to 90Y radioembolization using dynamic contrast material– enhanced MRI and intravoxel incoherent motion diffusion-weighted imaging
AU - Hectors, Stefanie J.
AU - Lewis, Sara
AU - Kennedy, Paul
AU - Bane, Octavia
AU - Said, Daniela
AU - Segall, Maxwell
AU - Schwartz, Myron
AU - Kim, Edward
AU - Taouli, Bachir
N1 - Publisher Copyright:
© RSNA, 2020.
PY - 2020/7
Y1 - 2020/7
N2 - Purpose: To quantify diffusion and perfusion changes in hepatocellular carcinoma (HCC) induced by yttrium 90 (90Y) radioemboliza-tion and to assess the value of dynamic contrast material–enhanced (DCE) MRI and intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) for predicting HCC response. Materials and Methods: Institutional review board approval was obtained for this prospective study (clinical trial registry NCT01871545). Twenty-four participants with HCC (mean age, 69 years ± 9 [standard deviation], 18 men) underwent multiparametric MRI, includ-ing IVIM DWI and gadoxetic acid DCE MRI before (n = 24) and 6 weeks (n = 21) after radioembolization. IVIM DWI and DCE MRI histogram parameters were quantified in HCCs and liver parenchyma. HCC response was assessed by using modified Response Evaluation Criteria in Solid Tumors at 6 weeks and 6–12 months after radioembolization. Logistic regression analysis was used to evaluate the diagnostic performance of baseline MRI and clinical parameters for prediction of response. Results: Twenty-five HCCs were analyzed (mean size, 3.6 cm ± 1.9). Radioembolization resulted in significantly decreased perfusion (DCE MRI arterial flow, P = .002; IVIM pseudodiffusion coefficient [D*], P = .014). Multivariate logistic regression selected combined serum α-fetoprotein and portal flow (Fp) skewness (area under the curve [AUC] = 0.924) and combined D* standard deviation and Fp kurtosis (AUC = 0.916) for prediction of objective and complete response at 6 weeks, respectively. Standard deviation of DCE MRI parameter arterial fraction was selected as the optimal predictor for complete response at 6–12 months (AUC = 0.857). Conclusion: Diffusion and perfusion MRI can be used to evaluate the response of HCC to radioembolization. Pretreatment DCE MRI histogram parameters may be useful for radioembolization treatment stratification.
AB - Purpose: To quantify diffusion and perfusion changes in hepatocellular carcinoma (HCC) induced by yttrium 90 (90Y) radioemboliza-tion and to assess the value of dynamic contrast material–enhanced (DCE) MRI and intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) for predicting HCC response. Materials and Methods: Institutional review board approval was obtained for this prospective study (clinical trial registry NCT01871545). Twenty-four participants with HCC (mean age, 69 years ± 9 [standard deviation], 18 men) underwent multiparametric MRI, includ-ing IVIM DWI and gadoxetic acid DCE MRI before (n = 24) and 6 weeks (n = 21) after radioembolization. IVIM DWI and DCE MRI histogram parameters were quantified in HCCs and liver parenchyma. HCC response was assessed by using modified Response Evaluation Criteria in Solid Tumors at 6 weeks and 6–12 months after radioembolization. Logistic regression analysis was used to evaluate the diagnostic performance of baseline MRI and clinical parameters for prediction of response. Results: Twenty-five HCCs were analyzed (mean size, 3.6 cm ± 1.9). Radioembolization resulted in significantly decreased perfusion (DCE MRI arterial flow, P = .002; IVIM pseudodiffusion coefficient [D*], P = .014). Multivariate logistic regression selected combined serum α-fetoprotein and portal flow (Fp) skewness (area under the curve [AUC] = 0.924) and combined D* standard deviation and Fp kurtosis (AUC = 0.916) for prediction of objective and complete response at 6 weeks, respectively. Standard deviation of DCE MRI parameter arterial fraction was selected as the optimal predictor for complete response at 6–12 months (AUC = 0.857). Conclusion: Diffusion and perfusion MRI can be used to evaluate the response of HCC to radioembolization. Pretreatment DCE MRI histogram parameters may be useful for radioembolization treatment stratification.
UR - http://www.scopus.com/inward/record.url?scp=85106742041&partnerID=8YFLogxK
U2 - 10.1148/rycan.2020190094
DO - 10.1148/rycan.2020190094
M3 - Article
C2 - 32803165
AN - SCOPUS:85106742041
SN - 2638-616X
VL - 2
JO - Radiology: Imaging Cancer
JF - Radiology: Imaging Cancer
IS - 4
M1 - e190094
ER -